5221 - 5230 of 9117 Results
Title
Year
-
OPENTitle: Current safety recommendations for handling mouse and human αsynuclein pre-formed fibrilsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 206Issue #:Start Page: 106820End Page: 106820Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2025.106820Best OA location URL: https://doi.org/10.1016/j.nbd.2025.106820Citation Count: 5
-
OPENTitle: Contrast Acuity With Different Colors in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 6Issue #: 8Start Page: 672End Page: 677Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12821Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12821Citation Count: 7
- Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein gene2016RESTRICTEDTitle: Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein geneJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 35Issue #:Start Page: 82End Page: 87Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.12.002Citation Count: 31
- An mGlu4‐Positive Allosteric Modulator Alleviates Parkinsonism in Primates2018RESTRICTEDTitle: An mGlu4‐Positive Allosteric Modulator Alleviates Parkinsonism in PrimatesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1619End Page: 1631Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27462Citation Count: 58
- A novel homozygous SQSTM1 frameshift variant in a Filipino adolescent with childhood-onset ataxia and gaze palsy2026RESTRICTEDTitle: A novel homozygous SQSTM1 frameshift variant in a Filipino adolescent with childhood-onset ataxia and gaze palsyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol:Issue #:Start Page: 108233End Page: 108233Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2026.108233Citation Count: 1
- Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism2019RESTRICTEDTitle: Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonismJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 158Issue #:Start Page: 107725End Page: 107725Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.107725Citation Count: 40
-
OPENTitle: Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein FibrilsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 58Issue #: 15Start Page: 6002End Page: 6017Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b00571Best OA location URL: https://doi.org/10.7270/q24q7wrcCitation Count: 111
-
OPENTitle: Transglutaminase 2 Depletion Attenuates α-Synuclein Mediated Toxicity in MiceJournal Name: NeurosciencePublisher: Elsevier BVVol: 441Issue #:Start Page: 58End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.05.047Best OA location URL: https://doi.org/10.1016/j.neuroscience.2020.05.047Citation Count: 22
-
OPENTitle: Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson’s modelsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 4Start Page: 607End Page: 620Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-018-1873-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6123262Citation Count: 161
-
OPENTitle: LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In VivoJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 949End Page: 961Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-021-01007-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01007-8.pdfCitation Count: 17